Susquehanna Portfolio Strategies’s West Pharmaceutical WST Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.8M	Buy	119,345 +63,644	+114%	+$19.5M	0.68%	31
2026 Q1	$14M	Sell	55,701 -50,750	-48%	-$12.6M	0.21%	134
2025 Q4	$29.3M	Buy	106,451 +22,592	+27%	+$6.18M	0.45%	55
2025 Q3	$22M	Buy	+83,859	New	+$20.4M	0.35%	75
2024 Q2	–	Sell	-1,609	Closed	-$637K	–	760
2024 Q1	$637K	Sell	1,609 -3,884	-71%	-$1.44M	0.01%	538
2023 Q4	$1.93M	Buy	+5,493	New	+$1.94M	0.03%	439

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Susquehanna Portfolio Strategies's WST Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its West Pharmaceutical (WST) stake by 114% in Q2 2026, buying an estimated $19.5M and bringing the position to 119,345 shares worth $42.8M. The position accounts for 0.68% of the portfolio, ranked #31.

Susquehanna Portfolio Strategies first reported a position in WST in Q4 2023 and has held it in 6 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Susquehanna Portfolio Strategies held 119,345 shares of West Pharmaceutical worth $42.8M as of Q2 2026.
Susquehanna Portfolio Strategies bought 63,644 West Pharmaceutical shares in Q2 2026, an estimated $19.5M.
West Pharmaceutical made up 0.68% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #31 holding.
Susquehanna Portfolio Strategies first reported a position in West Pharmaceutical in Q4 2023 and has held it in 6 quarters since.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.